RHOT2 and neoplasm: At the molecular level, these mutants (MIRO2 159L) increased GCN1 binding, and MIRO2 277R decreased GCN1 binding (18); however, a potential effect of expression of these MIRO2 mutants in regulating tumor cell-intrinsic phenotypes was not explored.